Michael J. Fox Foundation

• Progenra

• Lysoway Therapeutics

• Vesper Bio

• Mitochon Pharmaceuticals

• NRG Therapeutics

  US$5m, 30 Oct 2024

• Mission Therapeutics

  US$5.2m, 2 Jul 2024

• Nine Square Therapeutics

  US$4.5m, 12 Sept 2023

Sources: progenra.com, lysoway.com, vesperbio.com, mitochonpharma.com, news.google.com, missiontherapeutics.com, ninesquaretx.com

• Evaluating inclusion of continuous multivariable cognitive scores for operational enrichment of preclinical Alzheimer's disease trials: a retrospective emulation study

  Consulting or advice, 8 Aug 2026

• Parkinson's disease impairs grip force release during a sinusoidal force tracking task

  Grants or research support, 18 Feb 2026

• Smoking-by-genotype interaction in type 2 diabetes risk and fasting glucose

  Consulting or advice, 7 May 2020

Sources: pubmed.ncbi.nlm.nih.gov

• Brain age prediction and early neurodegeneration detection using contrastive learning on brain biomechanics: a retrospective, multicentre study

  EBioMedicine, 2 Nov 2025